Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: survival returned 106 record(s)
|
|
Sunday, 07/30/2017
|
Nonparametric Bayesian Survival Models in a Demand Forecasting Application
Ta-Hsin Li, IBM Watson Research Center
2:05 PM
|
Integrative Boosting with Multiple Genomic Platforms Improves Prediction Accuracy for Survival Time in Cancer Patients
Kin Yau Wong, The University of North Carolina at Chapel Hill; Cheng Fan, The University of North Carolina at Chapel Hill; Maki Tanoika , The University of North Carolina at Chapel Hill; Joel S. Parker, The University of North Carolina at Chapel Hill; Andrew B. Nobel, The University of North Carolina at Chapel Hill; Donglin Zeng, University of North Carolina; Danyu Lin, University of North Carolina; Charles M. Perou, The University of North Carolina at Chapel Hill
2:20 PM
|
Borrowing Historical Information for Clinical Development - a Case Study
Guochen Song, Biogen; Peng Sun, Biogen; John Zhong, Biogen; Jie Li, Biogen; Baoguang Han, Biogen; Stacy Lindborg, Biogen
3:05 PM
|
Tree Based Weighted Learning for Estimating Individualized Treatment Rules with Censored Data
Yifan Cui, University of North Carolina at Chapel Hill; Ruoqing Zhu, University of Illinois Urbana-Champaign; Michael R Kosorok, University of North Carolina at Chapel Hill
3:20 PM
|
An Evaluation of Bias in Propensity Score Adjusted Nonlinear Regression Models
Fei Wan, University of Arkansas for Medical Sciences; Nandita Mitra, University of Pennslyvania
4:05 PM
|
On Corporate Bankruptcy Prediction
Yan Yu, University of Cincinnati; Aidong Ding, Northeastern University; Shaonan Tian, San Jose State University; Hui Guo, University of Cincinnati
4:05 PM
|
Using Longitudinal Biomarker Data to Dynamically Predict Time to Disease Progression
Xuelin Huang, M D Anderson Cancer Center; Fangrong Yan, China Pharmaceutical Univeristy; Ruosha Li, University of Texas Health Science Center at Houston; Jing Ning, University of Texas MD Anderson Cancer Center; Xiao Lin, China Pharmaceutical University/MD Anderson Cancer Center
4:30 PM
|
Censoring Unbiased Regression Trees and Ensembles
Robert Strawderman, University of Rochester
4:55 PM
|
|
Monday, 07/31/2017
|
Survival Prediction in Early-Stage Lung Cancer via Bayesian Model Averaging of Nonparametric Accelerated Failure Time Models
Kijoeng Nam, Merck; Nicholas Henderson, Johns Hopkins University ; Dai Feng, Merck
|
Analysis Timing in Oncology Immunotherapy Trials with a Late Separation of Overall Survival Curve
Shu-Chih Su, Merck
|
Semiparametric Bayes' Proportional Odds Models for Arbitrarily Censored Failure Time Data
Lu Wang, University of South Carolina; Lianming Wang, University of South Carolina
|
A Joint Model for Mixed and Censored Longitudinal Data and Survival Data, with Application to HIV Vaccine Studies
Tingting Yu; Lang Wu, UBC; Peter Gilbert, Fred Hutchinson Cancer Research Center
|
Enhancing Power of Case-Control Studies by Using Prevalent Cases
Marlena Maziarz, National Cancer Institute; Jing Qin, National Institute of Allergy and Infectious Diseases; Ruth Pfeiffer , National Cancer Institute, NIH, HHS
|
Combining Biomarkers for Risk Prediction Using Approximated Rank Correlation Statistic with Censored Survival Data
Eisuke Inoue, Medical Informatics, St. Marianna University School of Medicine
|
Time-to-event analysis when the event of interest is defined on a finite time interval and is subject to a competing risk
Catherine Lee; Sebastien Haneuse, TE-Harvard T.H. Chan School of Public Health
|
A Terminal Trend Model for Longitudinal Medical Cost Data and Survival
Qian Yang, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Tor D. Tosteson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Anna N. A. Tosteson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Jeffrey C. Munson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Zhigang Li, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
|
Methodologies for Clinical Trials Using Historical Control
Yeh-Fong Chen, US Food and Drug Administration
|
Using Random Survival Forest Modeling to Predict Research and Career Outcomes for the National Institutes of Health's Medical Scientist Training Program Trainees
Katie Patel, National Institutes of Health, Office of Extramural Research; Deepshikha Roychowdhury, National Institute of Health, Office of Extramural Research; Katrina Pearson, National Institutes of Health, Office of Extramural Research
|
A Simulation Based Clinical Trial Design for Time-To-Event Endpoint Using the Concept of Relative Time Utilizing the Generalized Integer Gamma Distribution
Milind Phadnis
8:50 AM
|
Envelopes for Censored Quantile Regression
Yue Zhao, KU Leuven; Zhihua Su, University of Florida; Ingrid Van Keilegom, KU Leuven; Shanshan Ding, University of Delaware
9:05 AM
|
An Empirical Saddlepoint Approximation Based Method for Smoothing Survival Functions Under Right Censoring
Adao Trindade, Texas Tech University; Pratheepa Jeganathan , Stanford University; Noroharivelo Randrianampy, HECMMA; Robert Paige, Missouri University of Science and Technology
9:15 AM
|
Evaluation of Hazard Ratio Estimators of Survival Data
Gang Li, Johnson & Johnson; Yining Wang, Johnson & Johnson; Weichung Joe Shih, Rutgers School of Public Health
9:20 AM
|
The Surrogate Threshold Effect for Event-Free Survival as a Potential Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia
Marc Buyse, IDDI Inc.; Richard Schlenk, University Hospital of Ulm, Germany; Hartmund Dohner, University Hospital of Ulm, Germany; Tomasz Burzykowski, IDDI S.A.
9:25 AM
|
Additive Rate Model for Recurrent Event Data with Intermittently Observed Time-Dependent Covariates
Tianmeng Lyu, Univ. Minnesota Biostatistics Dept.; Xianghua Luo, University of Minnesota; Chiung-Yu Huang, Johns Hopkins University
9:35 AM
|
Optimal Design of Experiments with the Observation Censoring Driven by Random Enrollment of Subjects
Xiaoqiang Xue; Valerii Fedorov, ICONplc
9:50 AM
|
Inference of on Time Specific Difference and Ratio of Kaplan-Meier Estimates
Jeong-Gun Park, Brigham & Womens Hospital / Harvard Medical School; Kelly Im, Brigham and Women's Hospital; Francesco Nordio, Brigham and Women's Hospital; Sabina Murphy, Brigham and Women's Hospital; Yared Gurmu, Brigham & Women's Hospital
9:50 AM
|
Assessing the Distribution of Discrete Survival Time in Presence of Recall Error
Sedigheh Mirzaei Salehabadi, NICHD; Rajeshwari Sundaram, NICHD
10:05 AM
|
Improving Dynamic Predictions from Joint Models of Longitudinal and Survival Data Using Time-Varying Effects
Dimitris Rizopoulos, Erasmus University Medical Center
10:35 AM
|
Methodologies for Clinical Trials Using Historical Control
Yeh-Fong Chen, US Food and Drug Administration
10:55 AM
|
Combining Biomarkers for Risk Prediction Using Approximated Rank Correlation Statistic with Censored Survival Data
Eisuke Inoue, Medical Informatics, St. Marianna University School of Medicine
11:00 AM
|
A Terminal Trend Model for Longitudinal Medical Cost Data and Survival
Qian Yang, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Tor D. Tosteson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Anna N. A. Tosteson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Jeffrey C. Munson, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Zhigang Li, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
11:30 AM
|
Soft-Thresholding Operator for Modeling Sparse Time Varying Effects in Survival Analysis
Yuan Yang, University of Michigan; Jian Kang, University of Michigan; Yi Li, University of Michigan
11:35 AM
|
Enhancing Power of Case-Control Studies by Using Prevalent Cases
Marlena Maziarz, National Cancer Institute; Jing Qin, National Institute of Allergy and Infectious Diseases; Ruth Pfeiffer , National Cancer Institute, NIH, HHS
11:40 AM
|
Nonparametric Group Sequential Methods for Combined Endpoints of Recurrent and Terminal Events from Multiple Follow-up Windows
Meng Xia, University of Michigan; Susan Murray, University of Michigan; Nabihah Tayob, The University of Texas MD Anderson Cancer Center
11:50 AM
|
On Effect Sizes for Nonparametric Comparison of Censored Survival Outcomes
Yongzhao Shao, New York University-School of Medicine; Zhaoyin Zhu, NYU
11:50 AM
|
Semiparametric Odds Ratio Model for Multivariate Survival Times
Hua Yun Chen, University of Illinois at Chicago
11:55 AM
|
Time-to-event analysis when the event of interest is defined on a finite time interval and is subject to a competing risk
Catherine Lee; Sebastien Haneuse, TE-Harvard T.H. Chan School of Public Health
11:55 AM
|
Effects of Unequal Censoring Time Distribution on the Analysis of Survival Data
Seongho Kim, Wayne State University; Hyejeong Jang, Wayne State University; Judith Abrams, Wayne State University
12:05 PM
|
Nonparametric Estimation of Median Survival Times with Applications to Multisite or Multicenter Studies
Mohammad Rahbar, University of Texas Health Science Center at Houston; Sangbum Choi, Korea University; Chuan Hong, Havard University T. Chan School of Public Health; Liang Zhu, University of Texas Health Science Center at Houston; Sangchoon Jeon , Yale University; Joseph C. Gardiner , Michigan State University
12:05 PM
|
Instrumental Variable Methods for Censored Data
Douglas Lehmann, University of Miami; Yun Li, University of Michigan; Douglas Earl Schaubel, University of Michigan
2:05 PM
|
Measuring Differential Treatment Benefit Across Marker Specific Subgroups: The Choice of Outcome Scale
Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center; Jaya Satagopan, Memorial Sloan Kettering Cancer Center
2:25 PM
|
A Robust and Powerful Microbiome-Based Association Test for Survival Traits
Hyunwook Koh, NYU School of Medicine; Huilin Li, New York University
2:25 PM
|
Dynamic Prediction of End-Stage Renal Disease Using Longitudinal Biomarkers in a Cohort Study of Chronic Kidney Disease
Liang Li, University of Texas MD Anderson Cancer Center
2:25 PM
|
Protecting Patient Privacy: Distributed Analyzes for Multisite Observational
Andrea J Cook, Group Health Research Institute
2:30 PM
|
Unified Methods for Variable Selection in Large-Scale Genomic Studies with Censored Survival Outcomes
Lauren Spirko, Temple University; Karthik Devarajan, Fox Chase Cancer Center
3:05 PM
|
A Flexible Joint Longitudinal-Survival Model for a Simultaneous Modeling of Multiple Longitudinal Biomarkers
Sepehr Akhavan Masouleh, UC Irvine; Babak Shahbaba, University of California, Irvine; Alexander Vandenberg-Rodes, UC Irvine; Daniel L. Gillen, University of California, Irvine
3:25 PM
|
|
Tuesday, 08/01/2017
|
Bayesian Nonparametric Inference for Bivariate Mean Residual Life Functions
Taha Monfared, csuf office of graduate studies; Valerie Poynor, California State University, Fullerton
|
Bayesian Hierarchical Reporting Delay Model in Infectious Disease Forecasting
Krzysztof Sakrejda, University of Massachusetts - Amherst; Nicholas G. Reich, University of Massachusetts Amherst; Stephen Lauer, University of Massachusetts - Amherst
|
Calibration and Discrimination in Predictive Survival Models
Yared Gurmu, Brigham and Women's Hospital; Jeong-Gun Park, Brigham & Womens Hospital / Harvard Medical School; Erica Goodrich, Brigham and Women's Hospital
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
|
Survival Analysis on a Social Network
SONG Fangda, The Chinese University of Hong Kong; Yingying Wei, The Chinese University of Hong Kong
|
A Method for Spatio-Temporal Back-Calculation of Cancer Incidence Rate
Nisheet Nautiyal; Theodore Holford, Yale University
|
Power Comparison of Tests of Restricted Mean Survival Time with Log-Rank Test and Generalized Wilcoxon Test Under Various Survival Distributions
Musashi Fukuda, Astellas Pharma Inc.; Yutaka Matsuyama, Department of Biostatistics, School of Public Health, The University of Tokyo
|
A Case Study Evaluating Time Varying Covariate and Competing Risk for Efficacy Evaluation in Survival Analyses
Yang Xu, BioStat Solutions, Inc.
|
Subgroup Analyzes with Survival Data in Retrospective Cohort Studies
Rima Izem, Food and Drug Administration; Jiemin Lao, Sphere Institute; Mao Hu, Acumen LLC; Yuqin Wei, Sphere Institute; Michael Wernecke, Acumen LLC; Jeffrey A Kelman, Centers for Medicaid and Medicare Services (CMS); David J Graham, Food and Drug Administration
|
Sample Size for Joint Testing Cause-Specific Hazard and Overall Hazard in the Presence of Competing Risks
Qing Yang, Duke University; Gang Li, University of California, Los Angeles
|
Joint Nonparametric Correction Estimator for Excess Relative Risk Regression in Survival Analysis with Exposure Measurement Error
Ching-Yun Wang, Fred Hutchinson Cancer Research Center; Harry Cullings, Radiation Effects Research Foundation; Xiao Song, University of Georgia; Kenneth J. Kopecky, Fred Hutchinson Cancer Research Center
8:35 AM
|
Mediation Analysis for Censored Survival Data Under an Accelerated Failure Time Model
Isabel Fulcher, Harvard T.H. Chan School of Public Health; Eric Tchetgen Tchetgen, Harvard University ; Paige L. Williams, Harvard T.H. Chan School of Public Health
8:35 AM
|
Semiparametric Regression on Life Lost
Lauren Balmert, University of Pittsburgh; Jong H. Jeong, University of Pittsburgh
8:35 AM
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
8:40 AM
|
Sample Size for Joint Testing Cause-Specific Hazard and Overall Hazard in the Presence of Competing Risks
Qing Yang, Duke University; Gang Li, University of California, Los Angeles
8:40 AM
|
A Method for Spatio-Temporal Back-Calculation of Cancer Incidence Rate
Nisheet Nautiyal; Theodore Holford, Yale University
8:45 AM
|
A Divide-And-Conquer Approach for Survival Analysis in Big Data
Shou-En Lu, Rutgers Department of Biostatistics; Jerry Q. Cheng, Rutgers Cardiovascular Institute of New Jersey; Minge Xie, Rutgers University
8:50 AM
|
Estimating the Effect of a Time-Dependent State Change on Correlated Recurrent and Terminal Events
Douglas Earl Schaubel, University of Michigan ; Abigail R. Smith, Arbor Research Collaborative for Health
8:55 AM
|
Bayesian Clinical Trial Design for Joint Models of Longitudinal and Survival Data
Joseph G Ibrahim, UNC; Matthew Psioda, UNC Chapel Hill
9:00 AM
|
Joint Modeling of Longitudinal and Survival Data with a Covariate Subject to a Limit of Detection
Abdus Sattar, Case Western Reserve University; Sanjoy K Sinha, Carleton University
9:25 AM
|
Power Comparison of Tests of Restricted Mean Survival Time with Log-Rank Test and Generalized Wilcoxon Test Under Various Survival Distributions
Musashi Fukuda, Astellas Pharma Inc.; Yutaka Matsuyama, Department of Biostatistics, School of Public Health, The University of Tokyo
9:30 AM
|
Optimal Individualized Early Warning for Inpatient Adverse Events
Hossein Soleimani, Johns Hopkins University; Suchi Saria, Johns Hopkins University
10:35 AM
|
Flexible parametric approach to classical measurement error variance estimation without auxiliary data
Ingrid Van Keilegom, ORSTAT, KU LEUVEN
10:35 AM
|
A Case Study Evaluating Time Varying Covariate and Competing Risk for Efficacy Evaluation in Survival Analyses
Yang Xu, BioStat Solutions, Inc.
10:40 AM
|
Subgroup Analyzes with Survival Data in Retrospective Cohort Studies
Rima Izem, Food and Drug Administration; Jiemin Lao, Sphere Institute; Mao Hu, Acumen LLC; Yuqin Wei, Sphere Institute; Michael Wernecke, Acumen LLC; Jeffrey A Kelman, Centers for Medicaid and Medicare Services (CMS); David J Graham, Food and Drug Administration
10:50 AM
|
Survival Analysis on a Social Network
SONG Fangda, The Chinese University of Hong Kong; Yingying Wei, The Chinese University of Hong Kong
11:35 AM
|
The Cost of Comparing Survival Curves Using Multiple Measures
Godwin Yung, Takeda Pharmaceutical; Yi Liu, Takeda; Mingxiu Hu, Takeda Pharmaceutical
2:05 PM
|
A Versatile Test Based on Restricted Mean Survival Time for Time-To-Event Outcomes
Miki Horiguchi, Kitasato University; Hajime Uno, Dana Farber Cancer Institute
2:20 PM
|
Joint Models of Longitudinal Ordinal Outcomes with Competing Risks Survival Analysis
Xiao Fang, University of Texas Medical Branch; Kristofer Jennings, University of Texas Medical Branch
2:35 PM
|
Model Averaged Accelerated Failure-Time Models for Modeling Chemical Risk
Matthew Wheeler
3:05 PM
|
Transformation Models for Doubly-Censored and Clustered Survival Data
Jane-Ling Wang, University of California, Davis; Cong Xu, Stanford University; Yuru Su, Fred Hutchinson Cancer Research Center
3:20 PM
|
|
Wednesday, 08/02/2017
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
|
Effect Modifications of Blood Lead-Cardiovascular Disease Mortality Association by Time-Related Factors Studied Using NHANES Linked Mortality Files
Yutaka Aoki, National Center for Health Statistics; Jennifer Parker, National Center for Health Statistics
|
Assessing the impact of informative censoring on overall survival in a RWD source.
Bill Capra, Genentech Inc.; Gillis Carrigan, Genentech Inc.; Michael Taylor, Genentech Inc.; Brandon Arnieri, Genentech Inc.; Melissa Curtis, Flatiron Health; Sandy Griffith, Flatiron Health; Aracelis Torres, Flatiron Health; Philip Hofmeister, Flatiron Health; Anala Gossai, Flatiron Health; Samuel Whipple, Genentech Inc; Peter Lambert, Genentech Inc
9:00 AM
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
9:10 AM
|
Attribute-Based Module Detection for the Elucidation of Tissue-Specific Pathways for Oncoimmunology
Han Yu, State University of New York at Buffalo; Rachael Hageman Blair, State University of New York at Buffalo
9:15 AM
|
Semiparametric Temporal Process Regression for Prevalence Modeling of Data Subject to Dependent Censoring
Tianyu Zhan, Biostatistics, University of Michigan; Douglas Earl Schaubel, University of Michigan
9:20 AM
|
Constructing Cohorts That Mimic the Survival Experience in Published Survival Analyses
Abhijit Das Gupta, ARAASTAT
9:35 AM
|
Effect Modifications of Blood Lead-Cardiovascular Disease Mortality Association by Time-Related Factors Studied Using NHANES Linked Mortality Files
Yutaka Aoki, National Center for Health Statistics; Jennifer Parker, National Center for Health Statistics
10:05 AM
|
Mendelian randomization for survival outcomes using semiparametric transformation models
Yen-Tsung Huang, Academia Sinica
10:35 AM
|
Using the Entire History in the Analysis of Nested Case Cohort Samples
Claudia Rivera, Harvard University
11:35 AM
|
Comparing Cross Validation Methods for Penalized Cox Regression
Biyue Dai, University of Iowa; Patrick Breheny, University of Iowa
11:50 AM
|
Design and Analysis of Single Arm Clinical Trials Involving Highly Heterogeneous Subjects
Sherry Liu, FDA
11:55 AM
|
Copula-Based Score Test for Large-Scale Bivariate Time-To-Event Data, with an Application to a Genetic Study of AMD Progression
Yi Liu; Ying Ding, University of Pittsburgh; Wei Chen, University of Pittsburgh
2:05 PM
|
Semiparametric Single Index Regression Models for Censored Outcomes
Jin Wang, UNC Chapel Hill; Donglin Zeng, University of North Carolina; Danyu Lin, University of North Carolina
2:20 PM
|
Constructing Trees with Censored Survival Data
Madan Kundu, Novartis Oncology Pharmaceuticals - Florham Park, NJ
2:35 PM
|
Concordance Probability: a View from Copula
Yilong Zhang, Merck Research Laboratories; Yongzhao Shao, New York University-School of Medicine
3:05 PM
|
Nonparametric Copula Estimation for Censored Data via Empirical Likelihood
Bin Dong
3:20 PM
|
|
Thursday, 08/03/2017
|
Bayesian Variable Selection for High-Dimensional Genomic Data with Survival Response
Amir Nikooienejad, Texas A&M University; Valen Johnson, Texas A&M University
8:50 AM
|
Instrumental Variable Restrictive Mean Survival Time Models
Xin Wang, University of Michigan; Douglas Earl Schaubel, University of Michigan
8:50 AM
|
Variable Selection for Case-Cohort Studies with Failure Time Outcome
Jianwen Cai, University of North Carolina at Chapel Hill; Ai Ni, Memorial Sloan Kettering Cancer Center; Donglin Zeng, University of North Carolina
8:55 AM
|
Within-Strata vs. Full-range Predictor Variable Multiple Imputation Procedures for Cox Models
Philimon Gona, University of Massachusetts Boston; Vasco Chikwasha, University of Zimbabwe College of Health Sciences; Sowmya R Rao, Boston University
9:05 AM
|
Integrated Powered Density: Screening Utrahigh-Dimensional Covariates with Survival Outcomes
Hyokyoung (Grace) Hong, Michigan State University; Yi Li, University of Michigan; Xuerong Chen, Southwest University of Finance and Economics
9:15 AM
|
Robust Procedure for Cure Models in Survival Analysis
Xiaoxia Han, NYU Langone Medical Center; Yilong Zhang, Merck Research Laboratories; Jia Bao, NYU Langone Medical Center; Yongzhao Shao, New York University-School of Medicine
9:20 AM
|
A Nonparametric Mixture of Semiparametric Bayesian Hierarchical Survival Models for Pathway Based Analysis
Lin Zhang, Virginia Tech; Inyoung Kim, Virginia Tech
9:35 AM
|
Optimizing Acute Myelogenous Leukemia Treatment Regimes via Sequential Conditional Structural Mean Models
Geoffrey Johnson, GlaxoSmithKline; Abdus Wahed, University of Pittsburgh
9:50 AM
|
Analyzing Mortality Following Breast Cancer Diagnosis in Louisiana SEER Data via a Spatial Accelerated Failure Time Model
Shanshan Zhao, National Institute of Environmental Health Sciences; Rachel Carroll, National Institute of Environmental Health Sciences; Andrew Lawson, Department of Public Health Sciences, Medical University of South Carolina
10:35 AM
|
Two Trends in Solutions to Computation-Intensive Methods: Laptop vs. Graphics Processing Unit (GPU)
Junshui Ma, Merck & Co., Inc.; Vladimir Svetnik, Merck & Co., Inc.
10:55 AM
|
Impact of Assessment of Schedule Interval Change on Median Progression-Free Survival Estimate
Shuyan Wan, Merck
11:05 AM
|
Robust Estimators for the Evaluation of Multiple Surrogate Markers with Censored Data
Layla Parast, RAND Corporation; Tianxi Cai, Harvard University; Lu Tian, Stanford University
11:25 AM
|
|
|
